A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

LESSONS LEARNED: This regimen is a viable option for patients with liver-only metastatic colorectal cancer. Enrollment criteria for future studies should include testing for the newly identified KRAS mutations. BACKGROUND. Patients with liver-only metastatic colorectal cancer (mCRC) who are not cand...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Bendell, Johanna C., Zakari, Ahmed, Peyton, James D., Boccia, Ralph, Moskowitz, Mark, Gian, Victor, Lipman, Andrew, Waterhouse, David, LoCicero, Richard, Earwood, Chris, Lane, Cassie M., Meluch, Anthony
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AlphaMed Press 2016
Pynciau:
Clinical Trial Results
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786359/
https://ncbi.nlm.nih.gov/pubmed/26911408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0439
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg